You are here:

NICE
NICE Guidance
Conditions and diseases
Respiratory conditions
Lung cancer

Lung cancer Products

A list of all our products on lung cancer

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceHealth technology evaluationInterventional procedures guidanceMedical technologies guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic selection

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
27 March 2025
Expected publication date:
30 April 2025
Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer [ID3949]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
26 March 2025
Expected publication date:
TBC